Biotest AG (ETR:BIO) | WebDisclosure

Basculer en Français

9480	Companies
185524	Keywords
117913	Articles
99371	Press releases

Home
Companies
Biotest AG

BRIEF

published on 02/29/2024 at 07:45, 1 year 9 months ago

Biotest announces performance in line with forecasts for 2023

Financial Results Biotest AG Turnover EBIT 2023 Preferential Dividend
PRESS RELEASE

published on 02/29/2024 at 07:45, 1 year 9 months ago

Biotest achieves EBIT forecast for 2023
Biotest achieves EBIT forecast for 2023, with EBIT of €143 million, meeting expectations. Sales reached €684 million, encompassing one-off effects. Final figures to be released on 28 March 2024

Financial Results Annual Report EBIT Forecast Biotest AG Preference Dividend
BRIEF

published on 02/28/2024 at 10:00, 1 year 9 months ago

Visite de Karl Lauterbach au centre de donation de plasma de Biotest AG à Cologne

Allemagne Biotest AG Don De Plasma Karl Lauterbach Soins Médicaux
BRIEF

published on 02/28/2024 at 10:00, 1 year 9 months ago

Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne

Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE

published on 02/28/2024 at 10:00, 1 year 9 months ago

Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care
Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply

Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
PRESS RELEASE

published on 02/14/2024 at 08:30, 1 year 9 months ago

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential

Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE

published on 11/28/2023 at 09:00, 2 years ago

EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE

published on 11/02/2023 at 08:00, 2 years 1 month ago

Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE

published on 10/05/2023 at 16:55, 2 years 2 months ago

EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE

published on 10/05/2023 at 16:42, 2 years 2 months ago

EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG

Accesswire

Published on 12/05/2025 at 18:45, 9 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 34 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 54 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 39 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 54 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:26, 27 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 38 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 2 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 7 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 53 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 36 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 36 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 43 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 43 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 55 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE